Latest news
Loading news…
Crucell researches and develops products and markets vaccines, proteins and antibodies for the treatment of infectious diseases.
Crucell Holland BV was acquired by Johnson & Johnson Services, Inc. in 2011 for $2.29B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- CRXL
- Exchange
- NASDAQ
- IPO date
- Oct 27, 2000
- Delisted
- Feb 22, 2011
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active products
- 4
- IT spend
- $8.82M
Company Info
- Founded
- 1993
- Employees
- 5001-10000
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 39
- HQ
- Leiden, Zuid-Holland, The Netherlands
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Oct 27, 2000
Signals & Scores
- Trend (7d)
- -0.1
- Trend (30d)
- -0.5
- Trend (90d)
- -0.8
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Crucell Holland BV
Loading news…
FAQs about Crucell Holland BV
People who checked this page also checked these
Browse the full Acquirezy directory.